Learn about DARZALEX FASPRO® + VRd, the latest FDA-approved quad treatment combination for people with newly diagnosed multiple myeloma who are not eligible to receive a stem cell transplant

Sign Up For Support

Learn about DARZALEX FASPRO ® + VRd, the latest FDA-approved quad treatment combination for people with newly diagnosed multiple myeloma who are not eligible to receive a stem cell transplant

Homepage Banner Desktop Image

Site Map

About Multiple Myeloma

What Is Multiple Myeloma?Understanding a DiagnosisUnderstanding Treatment OutcomesTreatment Options

About DARZALEX FASPRO® & DARZALEX®

What are DARZALEX FASPRO® & DARZALEX®?Frontline DARZALEX FASPRO® & DARZALEX®

Starting Treatment

Preparing for Treatment with DARZALEX FASPRO® or DARZALEX®How Treatment Is GivenWhat to Expect During TreatmentWhat to Expect After TreatmentDARZALEX FASPRO® and DARZALEX® Clinical Trial ResultsQuad DARZALEX FASPRO® Combination Treatment ResultsTriplet DARZALEX® Combination Treatment ResultsAdditional Clinical Studies

Staying on Treatment

Why Staying on DARZALEX® May Work for YouThe Original MAIA Clinical StudyPossible Side EffectsUnderstanding Medical Studies

Savings & Support

Discover DARZALEX withMePaying for TreatmentDedicated Care NavigatorAdditional Support & Community ConnectionsSign Up for Support

Patient Stories & Resources

Patient Stories & Resources

For Care Partners

For Care Partners